Form 8-K - Current report:
SEC Accession No. 0001193125-22-087464
Filing Date
2022-03-29
Accepted
2022-03-29 08:12:17
Documents
76
Period of Report
2022-03-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d277165d8k.htm   iXBRL 8-K 33725
2 EX-99.1 d277165dex991.htm EX-99.1 58330
3 EX-99.2 d277165dex992.htm EX-99.2 23874
7 GRAPHIC g277165ex99_1s10g1.jpg GRAPHIC 328069
8 GRAPHIC g277165ex99_1s11g1.jpg GRAPHIC 330308
9 GRAPHIC g277165ex99_1s12g1.jpg GRAPHIC 184876
10 GRAPHIC g277165ex99_1s13g1.jpg GRAPHIC 190627
11 GRAPHIC g277165ex99_1s14g1.jpg GRAPHIC 302801
12 GRAPHIC g277165ex99_1s15g1.jpg GRAPHIC 449492
13 GRAPHIC g277165ex99_1s16g1.jpg GRAPHIC 379346
14 GRAPHIC g277165ex99_1s17g1.jpg GRAPHIC 279554
15 GRAPHIC g277165ex99_1s18g1.jpg GRAPHIC 192202
16 GRAPHIC g277165ex99_1s19g1.jpg GRAPHIC 223866
17 GRAPHIC g277165ex99_1s1g1.jpg GRAPHIC 355592
18 GRAPHIC g277165ex99_1s20g1.jpg GRAPHIC 218257
19 GRAPHIC g277165ex99_1s21g1.jpg GRAPHIC 193036
20 GRAPHIC g277165ex99_1s22g1.jpg GRAPHIC 189979
21 GRAPHIC g277165ex99_1s23g1.jpg GRAPHIC 173384
22 GRAPHIC g277165ex99_1s24g1.jpg GRAPHIC 349433
23 GRAPHIC g277165ex99_1s25g1.jpg GRAPHIC 258367
24 GRAPHIC g277165ex99_1s26g1.jpg GRAPHIC 181342
25 GRAPHIC g277165ex99_1s27g1.jpg GRAPHIC 260864
26 GRAPHIC g277165ex99_1s28g1.jpg GRAPHIC 175217
27 GRAPHIC g277165ex99_1s29g1.jpg GRAPHIC 176921
28 GRAPHIC g277165ex99_1s2g1.jpg GRAPHIC 232339
29 GRAPHIC g277165ex99_1s30g1.jpg GRAPHIC 241653
30 GRAPHIC g277165ex99_1s31g1.jpg GRAPHIC 165108
31 GRAPHIC g277165ex99_1s32g1.jpg GRAPHIC 157658
32 GRAPHIC g277165ex99_1s33g1.jpg GRAPHIC 215072
33 GRAPHIC g277165ex99_1s34g1.jpg GRAPHIC 209485
34 GRAPHIC g277165ex99_1s35g1.jpg GRAPHIC 217128
35 GRAPHIC g277165ex99_1s36g1.jpg GRAPHIC 117994
36 GRAPHIC g277165ex99_1s37g1.jpg GRAPHIC 179518
37 GRAPHIC g277165ex99_1s38g1.jpg GRAPHIC 154471
38 GRAPHIC g277165ex99_1s39g1.jpg GRAPHIC 133709
39 GRAPHIC g277165ex99_1s3g1.jpg GRAPHIC 678005
40 GRAPHIC g277165ex99_1s40g1.jpg GRAPHIC 194321
41 GRAPHIC g277165ex99_1s41g1.jpg GRAPHIC 196526
42 GRAPHIC g277165ex99_1s42g1.jpg GRAPHIC 135038
43 GRAPHIC g277165ex99_1s43g1.jpg GRAPHIC 177295
44 GRAPHIC g277165ex99_1s44g1.jpg GRAPHIC 128179
45 GRAPHIC g277165ex99_1s45g1.jpg GRAPHIC 148963
46 GRAPHIC g277165ex99_1s46g1.jpg GRAPHIC 163941
47 GRAPHIC g277165ex99_1s47g1.jpg GRAPHIC 165362
48 GRAPHIC g277165ex99_1s48g1.jpg GRAPHIC 253659
49 GRAPHIC g277165ex99_1s49g1.jpg GRAPHIC 257608
50 GRAPHIC g277165ex99_1s4g1.jpg GRAPHIC 228705
51 GRAPHIC g277165ex99_1s50g1.jpg GRAPHIC 157826
52 GRAPHIC g277165ex99_1s51g1.jpg GRAPHIC 249099
53 GRAPHIC g277165ex99_1s52g1.jpg GRAPHIC 330459
54 GRAPHIC g277165ex99_1s53g1.jpg GRAPHIC 404694
55 GRAPHIC g277165ex99_1s54g1.jpg GRAPHIC 326454
56 GRAPHIC g277165ex99_1s55g1.jpg GRAPHIC 335122
57 GRAPHIC g277165ex99_1s56g1.jpg GRAPHIC 421777
58 GRAPHIC g277165ex99_1s57g1.jpg GRAPHIC 339310
59 GRAPHIC g277165ex99_1s58g1.jpg GRAPHIC 192967
60 GRAPHIC g277165ex99_1s59g1.jpg GRAPHIC 220722
61 GRAPHIC g277165ex99_1s5g1.jpg GRAPHIC 375543
62 GRAPHIC g277165ex99_1s60g1.jpg GRAPHIC 254291
63 GRAPHIC g277165ex99_1s61g1.jpg GRAPHIC 346830
64 GRAPHIC g277165ex99_1s6g1.jpg GRAPHIC 399018
65 GRAPHIC g277165ex99_1s7g1.jpg GRAPHIC 272221
66 GRAPHIC g277165ex99_1s8g1.jpg GRAPHIC 328873
67 GRAPHIC g277165ex99_1s9g1.jpg GRAPHIC 266452
68 GRAPHIC g277165g0328132328193.jpg GRAPHIC 3316
  Complete submission text file 0001193125-22-087464.txt   21443944

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aldx-20220329.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20220329_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20220329_pre.xml EX-101.PRE 11262
70 EXTRACTED XBRL INSTANCE DOCUMENT d277165d8k_htm.xml XML 3356
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 22777485
SIC: 2834 Pharmaceutical Preparations